Referências
Artigos de referência
1. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynaecol Obstet. 2020 Jun;149(3):273-86.Texto completo Resumo
2. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2021 Mar 12:70(10);355-61.Texto completo Resumo
3. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-54.Texto completo Resumo
4. International Federation of Gynecology and Obstetrics. Safe motherhood and COVID-19 – March 2021 update. 2021 [internet publication].Texto completo
5. Epelboin S, Labrosse J, De Mouzon J, et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: a national retrospective cohort study. PLoS Med. 2021 Nov 30;18(11):e1003857.Texto completo Resumo
6. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020 Jun 26;69(25):769-75.Texto completo
7. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and pregnancy. Dec 2022 [internet publication].Texto completo
8. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020 Jun 8;369:m2107.Texto completo Resumo
9. Thoma ME, Declercq ER. Changes in pregnancy-related mortality associated with the coronavirus disease 2019 (COVID-19) pandemic in the United States. Obstet Gynecol. 2023 May 1;141(5):911-7. Resumo
10. Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020 Sep 23;324(17):1782-5.Texto completo Resumo
11. Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635-40.Texto completo Resumo
12. Jering KS, Claggett BL, Cunningham JW, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021 May 1;181(5):714-7.Texto completo Resumo
13. Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021 Nov;225(5):522.e1-522.e11.Texto completo Resumo
14. Piekos SN, Roper RT, Hwang YM, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit Health. 2022 Jan 13;4(2):e95-104.Texto completo Resumo
15. Marchand G, Patil AS, Masoud AT, et al. Systematic review and meta-analysis of COVID maternal and neonatal clinical features and pregnancy outcomes to June 3rd 2021. AJOG Glob Rep. 2022 Feb;2(1):100049.Texto completo Resumo
16. Metz TD, Clifton RG, Hughes BL, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022 Feb 22;327(8):748-59.Texto completo Resumo
17. Ferrara A, Hedderson M, Zhu Y, et al. Perinatal complications in individuals in California with or without SARS-CoV-2 infection during pregnancy. JAMA Intern Med. 2022 May 1;182(5):503-12.Texto completo Resumo
18. McClymont E, Albert AY, Alton GD, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2 May 2022 [Epub ahead of print].Texto completo Resumo
19. Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics — eight U.S. health care centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 23;69(38):1355-9.Texto completo Resumo
20. Khoury R, Bernstein PS, Debolt C, et al. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstet Gynecol. 2020 Aug;136(2):273-82.Texto completo Resumo
21. Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021 Apr 1;137(4):571-80.Texto completo Resumo
22. Villar J, Soto Conti CP, Gunier RB, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023 Feb 11;401(10375):447-57.Texto completo Resumo
23. Flaherman VJ, Afshar Y, Boscardin J, et al. Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study. Clin Infect Dis. 2021 Nov 2;73(9):e2810-13.Texto completo Resumo
24. Norman M, Navér L, Söderling J, et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA. 2021 May 25;325(20):2076-86.Texto completo Resumo
25. DeSisto CL, Wallace BL, Simeone RM, et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization - United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1640-45.Texto completo Resumo
26. Magnus MC, Örtqvist AK, Urhoj SK, et al. Infection with SARS-CoV-2 during pregnancy and risk of stillbirth: a Scandinavian registry study. BMJ Public Health 2023 Oct 31;1(1):e000314.Texto completo
27. Allotey J, Chatterjee S, Kew T, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022 Mar 16;376:e067696.Texto completo Resumo
28. International Federation of Gynecology and Obstetrics. COVID-19 vaccination for pregnant and breastfeeding women. Mar 2021 [internet publication].Texto completo
29. American College of Obstetricians and Gynecologists (ACOG). COVID-19 vaccination considerations for obstetric–gynecologic care. Sep 2023 [internet publication].Texto completo
30. Centers for Disease Control and Prevention. Information about COVID-19 vaccines for people who are pregnant or breastfeeding. Nov 2023 [internet publication].Texto completo
31. UK Health Security Agency. COVID-19: the green book, chapter 14a: Coronavirus (COVID-19) vaccination information for public health professionals. Sep 2023 [internet publication].Texto completo
32. Prasad S, Kalafat E, Blakeway H, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022 May 10;13(1):2414.Texto completo Resumo
33. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 vaccination in pregnancy with adverse peripartum outcomes. JAMA. 2022 Apr 19;327(15):1478-87.Texto completo Resumo
34. Magnus MC, Örtqvist AK, Dahlqwist E, et al. Association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes. JAMA. 2022 Apr 19;327(15):1469-77.Texto completo Resumo
35. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021 Jun 17;384(24):2273-82.Texto completo Resumo
36. Zauche L, Wallace B, Smoots AN, et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N Engl J Med. 2021 Oct 14;385(16):1533-5.Texto completo Resumo
37. Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA. 2021 Oct 26;326(16):1629-31.Texto completo Resumo
38. Magnus MC, Gjessing HK, Eide HN. et al. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med. 2021 Nov 18;385(21):2008-10.Texto completo Resumo
39. Lipkind HS, Vazquez-Benitez G, DeSilva M, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):26-30.Texto completo Resumo
40. Hagrass AI, Almadhoon HW, Al-Kafarna M, et al. Maternal and neonatal safety outcomes after SAR-CoV-2 vaccination during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2022 Jul 21;22(1):581.Texto completo Resumo
41. Fell DB, Dimanlig-Cruz S, Regan AK, et al. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ. 2022 Aug 17;378:e071416.Texto completo Resumo
42. Watanabe A, Yasuhara J, Iwagami M, et al. Peripartum outcomes associated with COVID-19 vaccination during pregnancy: a systematic review and meta-analysis. JAMA Pediatr. 2022 Oct 3;176(11):1098-106.Texto completo Resumo
43. Rimmer MP, Teh JJ, Mackenzie SC, et al. The risk of miscarriage following COVID-19 vaccination: a systematic review and meta-analysis. Hum Reprod. 2023 May 2;38(5):840-52.Texto completo Resumo
44. Vousden N, Ramakrishnan R, Bunch K, et al. Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and delta variant dominance in the UK: prospective cohort study. BMJ Medicine. 2022 Mar 9;1:e000053.Texto completo
45. Adhikari EH, MacDonald L, SoRelle JA, et al. COVID-19 cases and disease severity in pregnancy and neonatal positivity associated with Delta (B.1.617.2) and Omicron (B.1.1.529) variant predominance. JAMA. 2022 Apr 19;327(15):1500-2.Texto completo Resumo
46. DeSilva M, Haapala J, Vazquez-Benitez G, et al. Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. N Engl J Med. 2022 Jul 14;387(2):187-9.Texto completo Resumo
47. Sadarangani M, Soe P, Shulha HP, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022 Nov;22(11):1553-64.Texto completo Resumo
48. Hillson K, Costa Clemens S, Madhi SA, et al. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet. 2021 Nov 6;398(10312):1683-4.Texto completo Resumo
49. Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gynecol. 25 Jan 2022 [Epub ahead of print].Texto completo Resumo
50. Magee LA, von Dadelszen P, Kalafat E, et al. COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm. Lancet Infect Dis. 2021 Dec;21(12):1627.Texto completo Resumo
51. Gill L, Jones C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol. 2021 May 1;137(5):894-6.Texto completo Resumo
52. Perl S, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021 May 18;325(19):2013-4.Texto completo Resumo
53. Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021 Sep;225(3):303.Texto completo Resumo
54. Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr. 2021 Jun 1;175(6):594-600.Texto completo Resumo
55. Munoz FM, Posavad CM, Richardson BA, et al. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. Vaccine. 2023 Aug 14;41(36):5296-303.Texto completo Resumo
56. Kugelman N, Nahshon C, Shaked-Mishan P, et al. Maternal and neonatal severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G levels after the Pfizer-BioNTech booster dose for Coronavirus disease 2019 (COVID-19) vaccination during the second trimester of pregnancy. Obstet Gynecol. 2022 Aug 1;140(2):187-93.Texto completo Resumo
57. Halasa NB, Olson SM, Staat MA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months - 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):264-70.Texto completo Resumo
58. Carlsen EØ, Magnus MC, Oakley L, et al. Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants. JAMA Intern Med. 2022 Aug 1;182(8):825-31.Texto completo Resumo
59. Halasa NB, Olson SM, Staat MA, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. 2022 Jul 14;387(2):109-19.Texto completo Resumo
60. Jorgensen SCJ, Hernandez A, Fell DB, et al. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ. 2023 Feb 8;380:e074035.Texto completo Resumo
61. American Academy of Pediatrics. FAQs: management of infants born to mothers with suspected or confirmed COVID-19. Dec 2021 [internet publication].Texto completo
62. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020 Oct;4(10):721-7.Texto completo Resumo
63. Dumitriu D, Emeruwa UN, Hanft E, et al. Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City. JAMA Pediatr. Oct 2020 [internet publication].Texto completo Resumo
64. Ronchi A, Pietrasanta C, Zavattoni M, et al. Evaluation of rooming-in practice for neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection in Italy. JAMA Pediatr. 2021 Mar 1;175(3):260-6.Texto completo Resumo
65. World Health Organization. Clinical management of COVID-19: living guidance. Nov 2021 [internet publication].Texto completo
66. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics. Mar 2022 [internet publication].Texto completo
67. Centers for Disease Control and Prevention. Care for breastfeeding women. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. Jun 2021 [internet publication].Texto completo
68. Chambers C, Krogstad P, Bertrand K, et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020 Oct 6;324(13):1347-8.Texto completo Resumo
69. Centers for Disease Control and Prevention. Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals. Feb 2023 [internet publication].Texto completo
70. American Society of Hematology. COVID-19 resources: treatment of COVID-19 in immunocompromised patients with hematologic conditions. Sep 2022 [internet publication].Texto completo
71. Teh JSK, Coussement J, Neoh ZCF, et al. Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis. Blood Adv. 2022 Apr 12;6(7):2014-34.Texto completo Resumo
72. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-45.Texto completo Resumo
73. Pike A, McKinley C, Forrest B, et al. COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria. Lancet Haematol. 2022 Aug;9(8):e553-6.Texto completo Resumo
74. American Association for the Study of Liver Diseases. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Nov 2021 [internet publication].Texto completo
75. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. 2021 Oct;217(4):831-4.Texto completo Resumo
76. Robinson KA, Maimone S, Gococo-Benore DA, et al. Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA Oncol. 2021 Sep 1;7(9):1395-7.Texto completo Resumo
77. Royal College of Paediatrics and Child Health. National guidance for the management of children with bronchiolitis and lower respiratory tract infections during COVID-19. Nov 2023 [internet publication].Texto completo
78. Resuscitation Council UK. Guidance: COVID-19. Aug 2022 [internet publication].Texto completo
79. Hsu A, Sasson C, Kudenchuk PJ, et al. 2021 Interim guidance to health care providers for basic and advanced cardiac life support in adults, children, and neonates with suspected or confirmed COVID-19. Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008396.Texto completo Resumo
80. Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-103.Texto completo Resumo
81. Carr EJ, Wu M, Harvey R, et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 Sep 18;398(10305):1038-41.Texto completo Resumo
82. Sibbel S, McKeon K, Luo J, et al. Real-world effectiveness and immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 vaccines in patients on hemodialysis. J Am Soc Nephrol. 2022 Jan;33(1):49-57.Texto completo Resumo
83. Hsu CM, Weiner DE, Manley HJ, et al. Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months. Clin J Am Soc Nephrol. 2022 Mar;17(3):403-13.Texto completo Resumo
84. Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021 Mar;33:100789.Texto completo Resumo
85. Bloom C, Drake T, Docherty A, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021 Jul;9(7):699-711.Texto completo Resumo
86. British Thoracic Society. COPD and COVID-19 for healthcare professionals. Apr 2020 [internet publication].Texto completo
87. Boettler T, Marjot T, Newsome PN, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep. 2020 Oct;2(5):100169.Texto completo Resumo
88. Große K, Kramer M, Trautwein C, et al. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure. Liver Int. 2020 Jul;40(7):1792-3.Texto completo Resumo
89. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010 May;85(5):451-8.Texto completo Resumo
90. Marjot T, Webb GJ, Barritt AS, et al. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-8.Texto completo Resumo
91. John BV, Deng Y, Scheinberg A, et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021 Oct 1;181(10):1306-14.Texto completo Resumo
92. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19. Mar 2020 [internet publication].Texto completo
93. Alsaied T, Aboulhosn JA, Cotts TB, et al. Coronavirus disease 2019 (COVID-19) pandemic implications in pediatric and adult congenital heart disease. J Am Heart Assoc. 2020 Jun 16;9(12):e017224.Texto completo Resumo
94. Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021 May 14;42(19):1858-65.Texto completo Resumo
95. Ehwerhemuepha L, Roth B, Patel AK, et al. Association of congenital and acquired cardiovascular conditions with COVID-19 severity among pediatric patients in the US. JAMA Netw Open. 2022 May 2;5(5):e2211967.Texto completo Resumo
96. Radke RM, Frenzel T, Baumgartner H, et al. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302-09.Texto completo
97. McGurnaghan SJ, Weir A, Bishop J, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93.Texto completo Resumo
98. Ng WH, Tipih T, Makoah N, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9;12(1):e03647-20.Texto completo Resumo
99. Biswas M, Rahaman S, Biswas TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2020 Dec 9:1-12.Texto completo Resumo
100. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021 Feb;44(2):526-32.Texto completo Resumo
101. Longmore DK, Miller JE, Bekkering S, et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care. 2021 Jun;44(6):1281-90.Texto completo Resumo
102. Barrett CE, Park J, Kompaniyets L, et al. Intensive care unit admission, mechanical ventilation, and mortality among patients with type 1 diabetes hospitalized for COVID-19 in the U.S. Diabetes Care. 2021 Aug;44(8):1788-96.Texto completo Resumo
103. Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews. Diabetes Care. 2021 Dec;44(12):2790-811.Texto completo Resumo
104. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020 Oct;8(10):823–33.Texto completo Resumo
105. Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021 Jul;64(7):1480-91.Texto completo Resumo
106. Wong R, Hall M, Vaddavalli R, et al. Glycemic control and clinical outcomes in U.S. patients with COVID-19: data from the National COVID Cohort Collaborative (N3C) database. Diabetes Care. 2022 Feb 24;45(5):1099–106.Texto completo Resumo
107. Dennis JM, Mateen BA, Sonabend R, et al. Type 2 diabetes and COVID-19-related mortality in the critical care setting: a national cohort study in England, March-July 2020. Diabetes Care. 2020 Oct 23:dc201444.Texto completo Resumo
108. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020 Jul;43(7):1399-407.Texto completo Resumo
109. European AIDS Clinical Society. COVID-19 and HIV. BHIVA, DAIG, EACS, GESIDA & Polish Scientific AIDS Society. Statement on risk of COVID-19 for people living with HIV (PLWH). May 2020 [internet publication].Texto completo
110. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 Aug;9(8):909-23.Texto completo Resumo
111. Canadian Thoracic Society. Optimizing care for patients with interstitial lung disease during the COVID-19 pandemic. Aug 2020 [internet publication].Texto completo
112. Centers for Disease Control and Prevention. Morbidity and mortality weekly report: prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with influenza-United States, 2021-22 influenza season. Dec 2022 [internet publication].Texto completo
113. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Nov 2023 [internet publication].Texto completo
114. Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, Uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021 Mar 6;20(3):1-8.Texto completo Resumo
115. John TM, Jacob CN, Kontoyiannis DP, et al. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021 Apr 15;7(4):298.Texto completo Resumo
116. Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis. 2021 Sep 29;28(1).Texto completo Resumo
117. Mejía-Santos H, Montoya S, Chacón-Fuentes R, et al. Notes from the field: mucormycosis cases during the COVID-19 pandemic - Honduras, May-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-9.Texto completo Resumo
118. Dulski TM, DeLong M, Garner K, et al. Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1750-1.Texto completo Resumo
119. Muthu V, Agarwal R, Patel A, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect Dis. 4 Apr 2022 [Epub ahead of print].Texto completo Resumo
120. Department of Health Research Ministry of Health and Family Welfare Government of India. Evidence based advisory in the time of Covid-19. Screening, diagnosis & management of mucormycosis. 2021 [internet publication].Texto completo
121. Louapre C, Collongues N, Stankoff B, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020 Jun 26;77(9):1-10.Texto completo Resumo
122. Salter A, Fox RJ, Newsome SD, et al. Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis. JAMA Neurol. 2021 Jun 1;78(6):699-708.Texto completo Resumo
123. Achiron A, Mandel M, Dreyer-Alster S, et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835.Texto completo Resumo
124. Disanto G, Sacco R, Bernasconi E, et al. Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis. JAMA Neurol. 2021 Dec 1;78(12):1529-31.Texto completo Resumo
125. Brill L, Rechtman A, Zveik O, et al. Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2021 Dec 1;78(12):1510-4.Texto completo Resumo
126. König M, Torgauten HM, Tran TT, et al. Immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis and weak immune response after COVID-19 vaccination. JAMA Neurol. 2022 Mar 1;79(3):307-9.Texto completo Resumo
127. Madelon N, Heikkilä N, Sabater Royo I, et al. Omicron-specific cytotoxic T-cell responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2022 Apr 1;79(4):399-404.Texto completo Resumo
128. Centers for Disease Control and Prevention. COVID-19: people at increased risk and other people who need to take extra precautions. Mar 2022 [internet publication].Texto completo
129. Svensson P, Hofmann R, Häbel H, et al. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021 Feb 17;11(2):e044486.Texto completo Resumo
130. Public Health England. Excess weight and COVID-19: insights from new evidence. Jul 2020 [internet publication].Texto completo
131. Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry. Circulation. 2021 Jan 12;143(2):135-44.Texto completo Resumo
132. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov;21(11):e13128.Texto completo Resumo
133. Kompaniyets L, Goodman A, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-61.Texto completo Resumo
134. Arulanandam B, Beladi H, Chakrabarti A. COVID-19 mortality and the overweight: cross-country evidence. Public Health Pract (Oxf). 2021 Nov;2:100179.Texto completo Resumo
135. Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-9.Texto completo Resumo
136. Holt H, Talaei M, Greenig M, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 30 Nov 2021 [Epub ahead of print].Texto completo Resumo
137. Tadayon Najafabadi B, Rayner DG, Shokraee K, et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. Resumo
138. Mahamat-Saleh Y, Fiolet T, Rebeaud M, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021 Oct 25;11(10):e052777.Texto completo Resumo
139. Aminian A, Bena J, Pantalone KM, et al. Association of obesity with post-acute sequelae of COVID-19 (PASC). Diabetes Obes Metab. 2021 Sep;23(9):2183-8.Texto completo Resumo
140. Piernas C, Patone M, Astbury NM, et al. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2022 Aug;10(8):571-80.Texto completo Resumo
141. van der Klaauw AA, Horner EC, Pereyra-Gerber P, et al. Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nat Med. 2023 May;29(5):1146-54.Texto completo Resumo
142. MacKenna B, Kennedy NA, Mehrkar A, et al. Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. Lancet Rheumatol. 2022 Jul;4(7):e490-506.Texto completo Resumo
143. Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct;26(10):2473-6.Texto completo Resumo
144. Clift AK, Saatci D, Coupland CAC, et al. Sickle cell disorders and severe COVID-19 outcomes: a cohort study. Ann Intern Med. 2021 Oct;174(10):1483-7.Texto completo Resumo
145. Verma A, Huffman JE, Gao L, et al. Association of kidney comorbidities and acute kidney failure with unfavorable outcomes after COVID-19 in individuals with the sickle cell trait. JAMA Intern Med. 2022 Aug 1;182(8):796-804.Texto completo Resumo
146. Sickle Cell Disease Association of America. Sickle cell disease and COVID-19: provider advisory. May 2020 [internet publication].Texto completo
147. U.S. Food and Drug Administration. Possible false RPR reactivity with BioPlex 2200 Syphilis Total & RPR test kit following a COVID-19 vaccine - letter to clinical laboratory staff and health care providers. Dec 2021 [internet publication].Texto completo
148. Wang Q, Guo S, Wei X, et al. Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021). BMJ Open. 2022 Jun 20;12(6):e059396.Texto completo Resumo
149. Dheda D, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022 Mar 23 [Epub ahead of print].Texto completo Resumo
150. Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Jun 2022 [internet publication].Texto completo
151. Sperger J, Shah K, Lu M, et al. Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients. BMJ Open. 2021 Nov 12;11(11):e049740.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal